Drug Profile


Alternative Names: Beskoa; CWP-0403; SK-0403; Suiny

Latest Information Update: 02 Jun 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kyowa Hakko; Sanwa Kagaku Kenkyusho
  • Developer JW Pharmaceutical; Kowa Pharmaceutical; Sanwa Kagaku Kenkyusho
  • Class Antihyperglycaemics; Nitriles; Pyrazoles; Pyrimidines; Pyrrolidines; Small molecules
  • Mechanism of Action CD26 antigen inhibitors; Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Type 2 diabetes mellitus

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 30 Sep 2015 Sanwa Kagaku Kenkyusho and Kowa Company complete a phase III trial for Type-2 diabetes mellitus in Japan (PO) (JapicCTI-132246)
  • 30 Jun 2015 Phase-II development is ongoing in USA and European Union
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top